February 14, 2025

ATA Action Letter to DEA on Expansion of Buprenorphine Treatment via Telemedicine Encounter Final Rule

ATA Action Letter to DEA

ATA Action submitted comments in response to the DEA’s Expansion of Buprenorphine Treatment via Telemedicine Encounter Final Rule.